Ratio Therapeutics
Boston, United States· Est.
Ratio Therapeutics develops targeted radiopharmaceuticals for cancer treatment using its proprietary drug discovery platform.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $50M
About
Ratio Therapeutics develops targeted radiopharmaceuticals for cancer treatment using its proprietary drug discovery platform.
OncologyDrug Delivery
Funding History
1Total raised:$50M
PIPE$50M